Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06931470 · ClinicalTrials.gov registry record · NA

A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)

A NA study of Cardiovascular Diseases, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06931470 is a NA study of Cardiovascular Diseases that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 30 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06931470, a NA study of Cardiovascular Diseases, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the acceptability and efficacy of 12 weeks of: Smart-device app-based (MyZone) Asynchronous Virtual, Synchronous Virtual, and in-person aerobic training in individuals at risk for Cardiovascular Disease (CVD) who do are not meeting American Heart Association (AHA) guidelines for physical activity. The study aims to 1) Assess the effect of several approaches to remote aerobic training on measures of physical activity, cardiovascular fitness and CVD risk, and 2) Quantitatively and qualitatively evaluate exercise training program fidelity, implementation, effectiveness, and remaining barriers to acceptance. Participants will be asked to undergo Cardiopulmonary Exercise Testing (CPET) before and after 12-weeks of training via one of the 4 modalities (random assignment) listed above. They will respond to questions regarding acceptability of the interventions.

Conditions Studied

Cardiovascular Diseases

Interventions

  • BEHAVIORAL In-person supervised exercise sessions
  • BEHAVIORAL Virtual classes (live-streamed sessions)
  • BEHAVIORAL Self-directed aerobic exercise
  • DEVICE Myzone mobile application
  • DEVICE Map My Fitness mobile application

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-04-06
Est. Completion 2027-12-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06931470

The ClinicalTrials.gov registry entry for NCT06931470 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cardiovascular Diseases appearing as the primary indexed condition, and to 5 interventions - of which In-person supervised exercise sessions is the first listed.

NCT06931470 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06931470 about?

NCT06931470 is a clinical study titled "A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)". This study will investigate the acceptability and efficacy of 12 weeks of: Smart-device app-based (MyZone) Asynchronous Virtual, Synchronous Virtual, and in-person aerobic training in individuals at risk for Cardiovascular Disease (CVD) who do are not meeting American Heart Association (AHA) guideli...

What is the current status of trial NCT06931470?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-06. Estimated completion is 2027-12-01.

What conditions does trial NCT06931470 study?

This clinical trial studies the following conditions: Cardiovascular Diseases.

What interventions are being tested in trial NCT06931470?

The interventions under investigation include: In-person supervised exercise sessions (BEHAVIORAL), Virtual classes (live-streamed sessions) (BEHAVIORAL), Self-directed aerobic exercise (BEHAVIORAL), Myzone mobile application (DEVICE), Map My Fitness mobile application (DEVICE).

Who is sponsoring clinical trial NCT06931470?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06931470 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cardiovascular Diseases

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.